Norway· NO-ID_4CB66031-EEED-4AE7-9FDA-3EDA1583FC3B
Wainzua
A eplontersen product containing eplontersen sodium, registered in Norway by AstraZeneca AB. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Eplontersen is registered in 13 of 19 countries.
Countries holding a registration under ATC N07XX21 (eplontersen), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Eplontersen · ATC N07XX21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Eplontersen Sodium
- Manufacturer
- AstraZeneca AB
- Country
- Norway (NO)
- ATC code
- N07XX21
- ATC class
- Eplontersen
- Defined daily dose
- 1.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_4CB66031-EEED-4AE7-9FDA-3EDA1583FC3B
- no_varenummer5259011 x 0.8NOK 529999.1
- gtin5000456084871
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eplontersen in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumWainzua 45 mgAstraZeneca
- CzechiaWAINZUAAstraZeneca AB, Södertälje
- IcelandWainzuaAstraZeneca AB*
- SwedenWainzua 45 mg Injektionsvätska, lösning i förfylld injektionspennaAstraZeneca AB
- IrelandWainzua 45 mg solution for injection in pre-filled penAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Wainzua
- Liechtenstein · Wainzua
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db4f9cda-63cd-444f-a10f-f0509e0f7afb GET /v1/drugs/db4f9cda-63cd-444f-a10f-f0509e0f7afb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Eplontersen",
"merkevare_id": "ID_4CB66031-EEED-4AE7-9FDA-3EDA1583FC3B",
"name_form_strength": "Wainzua inj, oppl 45 mg",
"prescription_group": "C"
}See everything about eplontersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.